SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | – | 18 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | -100.0% | 18 | -87.3% | 0.00% | – |
| Q2 2022 | $4,000 | +100.0% | 142 | +71.1% | 0.00% | – |
| Q1 2022 | $2,000 | -77.8% | 83 | -74.9% | 0.00% | – |
| Q4 2021 | $9,000 | +50.0% | 331 | +5.1% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 315 | +25.5% | 0.00% | – |
| Q2 2020 | $6,000 | -25.0% | 251 | -44.6% | 0.00% | – |
| Q1 2020 | $8,000 | +166.7% | 453 | +248.5% | 0.00% | – |
| Q4 2019 | $3,000 | -91.7% | 130 | -89.9% | 0.00% | – |
| Q3 2019 | $36,000 | -18.2% | 1,293 | -2.3% | 0.00% | -100.0% |
| Q2 2019 | $44,000 | +15.8% | 1,323 | +22.3% | 0.00% | 0.0% |
| Q1 2019 | $38,000 | +245.5% | 1,082 | +232.9% | 0.00% | – |
| Q4 2018 | $11,000 | -31.2% | 325 | 0.0% | 0.00% | – |
| Q3 2018 | $16,000 | -15.8% | 325 | 0.0% | 0.00% | – |
| Q2 2018 | $19,000 | – | 325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 335,000 | $8,934,000 | 13.38% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,016,665 | $27,114,000 | 2.46% |
| Bruce & Co., Inc. | 402,105 | $10,724,000 | 2.28% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $7,934,000 | 1.91% |
| ARMISTICE CAPITAL, LLC | 3,900,000 | $104,013,000 | 1.76% |
| Bridge City Capital, LLC | 108,884 | $2,904,000 | 1.32% |
| S&T BANK/PA | 316,098 | $8,430,000 | 1.31% |
| Kent Lake Capital LLC | 100,000 | $2,667,000 | 1.15% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 331,140 | $8,832,000 | 1.02% |
| Prairiewood Capital, LLC | 45,297 | $1,208,000 | 0.99% |